BI
AERI

Boulegeris Investments’s Aerie Pharmaceuticals AERI Stock Holding History

Boulegeris Investments’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-66,540
Closed -$4.5M – 52
2018
Q2 		$4.5M Buy
66,540
+675
+1% +$37.8K 2.25% 9
2018
Q1 		$3.57M Sell
65,865
-4,500
-6% -$252K 1.96% 14
2017
Q4 		$4.2M Sell
70,365
-3,790
-5% -$230K 2.19% 10
2017
Q3 		$3.6M Sell
74,155
-5,370
-7% -$293K 2% 11
2017
Q2 		$4.18M Buy
79,525
+3,900
+5% +$182K 2.36% 8
2017
Q1 		$3.43M Sell
75,625
-5,310
-7% -$237K 2.05% 12
2016
Q4 		$3.06M Sell
80,935
-4,510
-5% -$171K 1.86% 13
2016
Q3 		$3.23M Sell
85,445
-6,325
-7% -$139K 2.04% 12
2016
Q2 		$1.61M Sell
91,770
-4,625
-5% -$74.9K 1.1% 22
2016
Q1 		$1.17M Buy
96,395
+1,295
+1% +$20.5K 0.83% 26
2015
Q4 		$2.32M Buy
95,100
+1,780
+2% +$41.5K 1.68% 18
2015
Q3 		$1.66M Buy
93,320
+4,660
+5% +$84.4K 1.27% 23
2015
Q2 		$1.56M Buy
88,660
+81,705
+1,175% +$1.5M 1.12% 24
2015
Q1 		$218K Buy
+6,955
New +$202K 0.16% 47

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Boulegeris Investments's AERI Position: Q3 2018 in Review

Boulegeris Investments sold out of Aerie Pharmaceuticals (AERI) in Q3 2018, closing a stake of 66,540 shares — an estimated $4.5M sold.

Boulegeris Investments first reported a position in AERI in Q1 2015 and held it in 14 quarters. The position peaked at $4.5M in Q2 2018. 176 funds tracked by Wall St. Rank hold AERI as of Q3 2018.

  • Boulegeris Investments reported no remaining Aerie Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Boulegeris Investments sold 66,540 Aerie Pharmaceuticals shares in Q3 2018, an estimated $4.5M.
  • Boulegeris Investments first reported a position in Aerie Pharmaceuticals in Q1 2015 and held it in 14 quarters.
  • Boulegeris Investments's Aerie Pharmaceuticals position peaked at $4.5M in Q2 2018.
  • 176 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2018.

Based on Boulegeris Investments's 13F filing for Q3 2018.